184 related articles for article (PubMed ID: 38557196)
1. IL-22-dependent responses and their role during
Melchior K; Gerner RR; Hossain S; Nuccio S-P; Moreira CG; Raffatellu M
Infect Immun; 2024 May; 92(5):e0009924. PubMed ID: 38557196
[TBL] [Abstract][Full Text] [Related]
2. Intestinal Epithelial Cells and the Microbiome Undergo Swift Reprogramming at the Inception of Colonic Citrobacter rodentium Infection.
Hopkins EGD; Roumeliotis TI; Mullineaux-Sanders C; Choudhary JS; Frankel G
mBio; 2019 Apr; 10(2):. PubMed ID: 30940698
[TBL] [Abstract][Full Text] [Related]
3. Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gamma.
Simmons CP; Goncalves NS; Ghaem-Maghami M; Bajaj-Elliott M; Clare S; Neves B; Frankel G; Dougan G; MacDonald TT
J Immunol; 2002 Feb; 168(4):1804-12. PubMed ID: 11823513
[TBL] [Abstract][Full Text] [Related]
4. The Citrobacter rodentium type III secretion system effector EspO affects mucosal damage repair and antimicrobial responses.
Berger CN; Crepin VF; Roumeliotis TI; Wright JC; Serafini N; Pevsner-Fischer M; Yu L; Elinav E; Di Santo JP; Choudhary JS; Frankel G
PLoS Pathog; 2018 Oct; 14(10):e1007406. PubMed ID: 30365535
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 receptor signaling protects mice from lethal intestinal damage caused by the attaching and effacing pathogen Citrobacter rodentium.
Lebeis SL; Powell KR; Merlin D; Sherman MA; Kalman D
Infect Immun; 2009 Feb; 77(2):604-14. PubMed ID: 19075023
[TBL] [Abstract][Full Text] [Related]
6. The p50 subunit of NF-kappaB is critical for in vivo clearance of the noninvasive enteric pathogen Citrobacter rodentium.
Dennis A; Kudo T; Kruidenier L; Girard F; Crepin VF; MacDonald TT; Frankel G; Wiles S
Infect Immun; 2008 Nov; 76(11):4978-88. PubMed ID: 18694964
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens.
Zheng Y; Valdez PA; Danilenko DM; Hu Y; Sa SM; Gong Q; Abbas AR; Modrusan Z; Ghilardi N; de Sauvage FJ; Ouyang W
Nat Med; 2008 Mar; 14(3):282-9. PubMed ID: 18264109
[TBL] [Abstract][Full Text] [Related]
8. Gamma interferon produced by antigen-specific CD4+ T cells regulates the mucosal immune responses to Citrobacter rodentium infection.
Shiomi H; Masuda A; Nishiumi S; Nishida M; Takagawa T; Shiomi Y; Kutsumi H; Blumberg RS; Azuma T; Yoshida M
Infect Immun; 2010 Jun; 78(6):2653-66. PubMed ID: 20351140
[TBL] [Abstract][Full Text] [Related]
9. Formyl peptide receptor 2 orchestrates mucosal protection against
Sharba S; Venkatakrishnan V; Padra M; Winther M; Gabl M; Sundqvist M; Wang J; Forsman H; Linden SK
Virulence; 2019 Dec; 10(1):610-624. PubMed ID: 31234710
[No Abstract] [Full Text] [Related]
10. EspF is crucial for Citrobacter rodentium-induced tight junction disruption and lethality in immunocompromised animals.
Xia X; Liu Y; Hodgson A; Xu D; Guo W; Yu H; She W; Zhou C; Lan L; Fu K; Vallance BA; Wan F
PLoS Pathog; 2019 Jun; 15(6):e1007898. PubMed ID: 31251784
[TBL] [Abstract][Full Text] [Related]
11. Activation of intestinal epithelial Stat3 orchestrates tissue defense during gastrointestinal infection.
Wittkopf N; Pickert G; Billmeier U; Mahapatro M; Wirtz S; Martini E; Leppkes M; Neurath MF; Becker C
PLoS One; 2015; 10(3):e0118401. PubMed ID: 25799189
[TBL] [Abstract][Full Text] [Related]
12. Bacterial virulence factor inhibits caspase-4/11 activation in intestinal epithelial cells.
Pallett MA; Crepin VF; Serafini N; Habibzay M; Kotik O; Sanchez-Garrido J; Di Santo JP; Shenoy AR; Berger CN; Frankel G
Mucosal Immunol; 2017 May; 10(3):602-612. PubMed ID: 27624779
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.
Khan MA; Ma C; Knodler LA; Valdez Y; Rosenberger CM; Deng W; Finlay BB; Vallance BA
Infect Immun; 2006 May; 74(5):2522-36. PubMed ID: 16622187
[TBL] [Abstract][Full Text] [Related]
14. Citrobacter rodentium: infection, inflammation and the microbiota.
Collins JW; Keeney KM; Crepin VF; Rathinam VA; Fitzgerald KA; Finlay BB; Frankel G
Nat Rev Microbiol; 2014 Sep; 12(9):612-23. PubMed ID: 25088150
[TBL] [Abstract][Full Text] [Related]
15. Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen.
Bry L; Brenner MB
J Immunol; 2004 Jan; 172(1):433-41. PubMed ID: 14688352
[TBL] [Abstract][Full Text] [Related]
16. T-cell derived acetylcholine aids host defenses during enteric bacterial infection with Citrobacter rodentium.
Ramirez VT; Godinez DR; Brust-Mascher I; Nonnecke EB; Castillo PA; Gardner MB; Tu D; Sladek JA; Miller EN; Lebrilla CB; Bevins CL; Gareau MG; Reardon C
PLoS Pathog; 2019 Apr; 15(4):e1007719. PubMed ID: 30973939
[TBL] [Abstract][Full Text] [Related]
17. TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium.
Lebeis SL; Bommarius B; Parkos CA; Sherman MA; Kalman D
J Immunol; 2007 Jul; 179(1):566-77. PubMed ID: 17579078
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of oral immunization with formalin-inactivated whole-cell Citrobacter rodentium on Citrobacter rodentium infection in mice.
Takahashi K; Hanamura Y; Tokunoh N; Kassai K; Matsunishi M; Watanabe S; Sugiyama T; Inoue N
J Microbiol Methods; 2019 Apr; 159():62-68. PubMed ID: 30817947
[TBL] [Abstract][Full Text] [Related]
19. Citrobacter rodentium-induced colitis: A robust model to study mucosal immune responses in the gut.
Koroleva EP; Halperin S; Gubernatorova EO; Macho-Fernandez E; Spencer CM; Tumanov AV
J Immunol Methods; 2015 Jun; 421():61-72. PubMed ID: 25702536
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-7 produced by intestinal epithelial cells in response to Citrobacter rodentium infection plays a major role in innate immunity against this pathogen.
Zhang W; Du JY; Yu Q; Jin JO
Infect Immun; 2015 Aug; 83(8):3213-23. PubMed ID: 26034215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
